Brooks Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹16.57 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 29.34 per cent from ₹23.45 crore. This corresponds to a year-on-year *(YoY) decline of 19.25 per cent.
Operating Profit
Operating Profit stands at ₹0.74 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 70.63 per cent from ₹2.52 crore. This corresponds to a year-on-year *(YoY) growth of 149.66 per cent.
PBDT
PBDT stands at ₹5.89 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 29.63 per cent from ₹8.37 crore. This corresponds to a year-on-year *(YoY) growth of 436.57 per cent.
Profit Before Tax
Profit Before Tax stands at ₹5.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.08 per cent from ₹7.98 crore. This corresponds to a year-on-year *(YoY) growth of 358.22 per cent.
Net Profit
Net Profit stands at ₹5.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.08 per cent from ₹7.98 crore. This represents a 358.22 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Brooks Laboratories Ltd Earnings
- YOY
- QOQ
Brooks Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Brooks Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Brooks Laboratories Ltd Financial Reports
Brooks Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Brooks Lab. | 0.85% | 0.91% | -24.45% | -33.87% | -52.25% | -64.61% |
| Coral Labs. | -4.73% | -2.04% | 4.95% | 3.42% | -11.15% | -38.33% |
| Natural Capsules | -8.12% | -1.21% | -6.42% | -6.48% | -16.13% | -23.78% |
| Lactose (India) | 0.45% | 3.74% | 11.15% | 25.73% | -3.63% | 18.56% |
| Alpa Laboratorie | -1.78% | 1.33% | -0.83% | -0.48% | -13.96% | -36.10% |
| Tyche Industries | -2.62% | -8.84% | 6.10% | 12.02% | 7.66% | -12.07% |
| Bal Pharma | 5.19% | 2.54% | 4.94% | 5.19% | 5.28% | -19.16% |
Company Info
Company Information
Chairman : Atul Ranchal
Managing Director : Rajesh Mahajan
Director & Chief Executive Off : Durga Sankar Maity
Independent Director : Rajnish Kumar Bedi
Independent Director : Deepak Mahajan
Independent Director : Sonia Gupta
Company Secretary : Jyoti Sancheti